| 1 |
32009527 | Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain. | 2020 Feb 4 |
3 |
| 2 |
26586373 | Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke. | 2016 Feb |
1 |
| 3 |
25648873 | Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand. | 2015 Jul |
1 |
| 4 |
24469880 | Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: the AVOCADO study. | 2013 |
3 |
| 5 |
19487018 | Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients. | 2010 Jan |
2 |
| 6 |
20069077 | PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin. | 2009 |
1 |
| 7 |
18281372 | Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure. | 2008 Jun 1 |
1 |
| 8 |
16780932 | Aspirin failure course during exercise and its connection with soluble CD40L. | 2007 |
1 |
| 9 |
16412866 | Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. | 2006 Jan 17 |
2 |
| 10 |
14730251 | Role of inflammation in stroke and atherothrombosis. | 2004 |
3 |